Evidence map›Paper›PMID 23754287›Full record

ArticleThe Journal of biological chemistry2013

Signaling to extracellular signal-regulated kinase from ErbB1 kinase and protein kinase C: feedback, heterogeneity, and gating.

Rebecca M Perrett, Robert C Fowkes, Christopher J Caunt, Krasimira Tsaneva-Atanasova, Clive G Bowsher, Craig A McArdle

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Information transfer by leaky, heterogeneous, protein kinase signaling systems.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  11. Biphasic responses in multi-site phosphorylation systems.Journal of the Royal Society, Interface · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca M PerrettFrom the Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Whitson Street, Bristol BS13NY, United Kingdom.
Robert C FowkesEndocrine Signaling Group, Royal Veterinary College, Royal College St., London NW10TU, United Kingdom.
Christopher J CauntDepartment of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA27AY, United Kingdom.
Krasimira Tsaneva-AtanasovaBristol Centre for Applied Nonlinear Mathematics, Department of Engineering Mathematics, University of Bristol, Bristol BS81TR, United Kingdom, and.
Clive G BowsherSchool of Mathematics, University of Bristol, Bristol BS81TW, United Kingdom.
Craig A McArdleFrom the Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Whitson Street, Bristol BS13NY, United Kingdom,. Electronic address: craig.mcardle@bristol.ac.uk.
University of Bristol · GBUniversity of Bath · GB

Funding

Medical Research Council G0701772Medical Research Council G0901763
6 · The paper itself

Abstract

Many extracellular signals act via the Raf/MEK/ERK cascade in which kinetics, cell-cell variability, and sensitivity of the ERK response can all influence cell fate. Here we used automated microscopy to explore the effects of ERK-mediated negative feedback on these attributes in cells expressing endogenous ERK or ERK2-GFP reporters. We studied acute rather than chronic stimulation with either epidermal growth factor (ErbB1 activation) or phorbol 12,13-dibutyrate (PKC activation). In unstimulated cells, ERK-mediated negative feedback reduced the population-average and cell-cell variability of the level of activated ppERK and increased its robustness to changes in ERK expression. In stimulated cells, negative feedback (evident between 5 min and 4 h) also reduced average levels and variability of phosphorylated ERK (ppERK) without altering the "gradedness" or sensitivity of the response. Binning cells according to total ERK expression revealed, strikingly, that maximal ppERK responses initially occur at submaximal ERK levels and that this non-monotonic relationship changes to an increasing, monotonic one within 15 min. These phenomena occur in HeLa cells and MCF7 breast cancer cells and in the presence and absence of ERK-mediated negative feedback. They were best modeled assuming distributive (rather than processive) activation. Thus, we have uncovered a novel, time-dependent change in the relationship between total ERK and ppERK levels that persists without negative feedback. This change makes acute response kinetics dependent on ERK level and provides a "gating" or control mechanism in which the interplay between stimulus duration and the distribution of ERK expression across cells could modulate the proportion of cells that respond to stimulation.

Indexed as

Feedback, PhysiologicalMAP Kinase Signaling SystemEnzyme ActivationEpidermal Growth FactorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesHeLa CellsHumansKineticsMCF-7 CellsMicroscopy, FluorescenceModels, BiologicalPhorbol 12,13-DibutyratePhosphorylationProtein Kinase CTime FactorsEpidermal Growth FactorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesPhorbol 12,13-DibutyrateProtein Kinase CCell SignalingEpidermal Growth Factor (EGF)ErbB1ERKFeedbackMAP Kinases (MAPKs)Protein Kinase C (PKC)

Identifiers

PMID23754287
PMCPMC3774369
OpenAlexW1995356376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.